Non-Vitamin K Anticoagulant is named as a drug or biological intervention in 2 clinical trials in our UK, USA and India trial registers, 1 of which is recruiting. Lead sponsors include Boston Scientific Corporation (1) and Population Health Research Institute (1). Registered phases: Not applicable and Phase 4. Conditions studied include Atrial Fibrillation; Stroke; Bleeding.
| NCT ID | Study | Phase | Status |
|---|---|---|---|
| NCT03968393 | Anticoagulation for Stroke Prevention In Patients With Recent Episodes of Atrial Fibrillation Occurring Transiently With Stress (ClinicalTrials.gov ↗) Stroke, Atrial Fibrillation |
Phase 4 | Recruiting |
| NCT04394546 | CHAMPION-AF Clinical Trial (ClinicalTrials.gov ↗) Atrial Fibrillation, Stroke, Bleeding |
Not applicable | Active, closed |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
| Condition (as registered) | Trials |
|---|---|
| Atrial Fibrillation | 2 |
| Stroke | 2 |
| Bleeding | 1 |
| Lead sponsor | Trials |
|---|---|
| Boston Scientific Corporation | 1 |
| Population Health Research Institute | 1 |
| Register | Non-Vitamin K Anticoagulant trials |
|---|---|
| Clinical trials in UK | 1 |
| Clinical trials in USA | 1 |
| Clinical trials in India | 1 |
A trial with sites in more than one country appears in each of those registers.
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how Non-Vitamin K Anticoagulant works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Non-Vitamin K Anticoagulant (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 24 Sep 2026.